Introduction
For the past several decades, Latin America and the Caribbean have experienced continuous and rapid changes in their demographic and epidemiological profiles that have directly affected life expectancy at birth 1, 2 . Although gains between quinquenniums have gradually slowed 3 , total life expectancy in the region increased 45 .5% between the periods of 1950-1955 and 2010-2015 (increasing from 51.2 to 74.5). The achievements influencing this indicator have depended largely on the reduction in childhood mortality, particularly the reduction of deaths caused by infectious and parasitic diseases 1, 2 , situating Latin America and the Caribbean as the developing region with the highest life expectancy 4 . However, the individual country view is mixed 5 .
Despite the economic and social progress achieved in the majority of Latin America and the Caribbean, inequalities between countries persist 6 , limiting the possibility of gaining years of life expectancy and accentuating the differences 1, 2 . The main obstacles include still elevated maternal and infant mortality rates (mainly prevalent in poor and marginalized areas) 2, 5 , malnutrition (undernutrition, overweight or obesity) 7 , rise of chronic diseases (particularly diabetes) 4, 8 , increase in violent deaths (homicides) 9, 10 and the increase in deaths caused by traffic accidents 11 (which largely affects people in working age). Some of these scenarios are influenced by the adoption of unhealthy lifestyles, including regular consumption of alcohol, tobacco and drugs, as well as physical inactivity and consumption of high-calorie diets rich in saturated fat, total fat and sugars 5 .
The leading causes of mortality in the Americas are noncommunicable diseases (NCD), particularly ischemic heart disease (9.2%), cerebrovascular disease (7.7%) and diabetes mellitus (6.5%). However, in some countries of the region, elevated maternal and infant mortality rates still prevail, in addition to communicable diseases (CD). Many of these diseases are potentially preventable and avoidable 11 , which could contribute to gains in years of life expectancy.
The objective of this paper was to analyze the level and trend of avoidable deaths (AD) and nonavoidable deaths (NAD) and their contribution to the change in life expectancy in Latin America by studying the situations in Argentina, Chile, Colombia and Mexico between 2000 and 2011, stratified by sex and 5-year age groups.
AD refer to those deaths that occur prematurely and unnecessarily, given the availability of resources and measures to mitigate them. These measures can include disease prevention, health promotion, therapeutic interventions, access to care and quality of care, among others 12, 13, 14, 15, 16 .
Materials and methods

Data
We conducted a descriptive and cross-sectional study. The information source of this study was the mortality vital statistics, and the population data were obtained from censuses or estimates from each country: in Colombia from the National Administrative Department of Statistics (Departamento Administrativo Nacional de Estadística -DANE; http://www.dane.gov.co/index.php/estadisticaspor-tema/demografia-y-poblacion, accessed on Jun/2016), in Chile from the National Institute of Statistics (Instituto Nacional de Estadísticas -INE; http://www.ine.cl/canales/chile_estadistico/ familias/demograficas_vitales.php, accessed on Jun/2016), in Argentina from the National Institute of Statistics and Censuses (Instituto Nacional de Estadística y Censos -INDEC; http://www.indec. mecon.ar/nivel2_default.asp?seccion=P&id_tema=2, accessed on Jun/2016), and in Mexico from the National Institute of Statistics and Geography (Instituto Nacional de Estadística y Geografía -INEGI)/Ministry of Health (Secretaría de Salud -SS; http://dgis.salud.gob.mx/cubos/, accessed on Jun/2015) and the National Population Council (Consejo Nacional de Población -CONAPO; http:// www.conapo.gob.mx/es/CONAPO/Proyecciones_Datos, accessed on Jul/2016). Nationwide data on deaths were obtained for the years 2000-2011, separated by causes of death, sex and 5-year age groups (from 0 to 74 years).
This study was based on the proposal by Nolte & McKee 17 , which considers 33 death causes grouped into 10 major categories (Table 1) . These causes are diseases (both chronic and infectious)
Cad. Saúde Pública 2018; 34(6):e00093417 susceptible to intervention, mainly through medical attention. The selection of death causes was performed according to the International Classification of Diseases, 10 th revision (ICD-10) 18 . In this sense, the group of avoidable causes of death was formed by those diseases considered in Table 1 ; meanwhile, we included the rest of the causes of death in the group of non-avoidable causes.
Table 1
Classification of causes of death considered avoidable.
Mortality causes
Age groups (years) ICD-10
Infectious disease
Intestinal infections 0-14 A00-A09 in which T 0 and T 75 are the total person-years lived from age 0 and 75, respectively, whereas l 0 are the survivors at exact age 0. To calculate the influence of different causes of death, by age groups, on the change in life expectancy, an extension of the model of Andreev et al. 20 was used. The change in temporary life expectancy 75 e 0 between time 1 (year 2000) and time 2 (year 2011) was obtained as follows 20 : in which:
with ; is the proportion of all deaths attributed to a specific cause of death j, at time i; n p x is the probability of a survivor with the exact age of x years in the life table of living n years; e x is the life expectancy at the exact age x; and indexes 1 and 2 indicate the initial and final years, respectively.
Decomposition techniques are a powerful tool to compare life expectancies across populations and time, and to analyze age and cause contributions to their differences 10, 21, 22 . The decomposition of changes in life expectancy was made using the temporary life expectancy between 0 and 74 years of age, following the classification of avoidable causes of death that only considers deaths under 75 years of age 18 .
Ethical considerations
As this study involves using information obtained from secondary sources that do not contain any individual identifiers, it poses no ethical problems. All the databases used in this study are publicly accessible. Figure 1 shows the trend in overall mortality rates and those caused by avoidable and non-avoidable causes, by sex and by country. In Argentina, Chile and Colombia, all the rates declined between the years 2000 and 2011; whereas, in Mexico, the AD and NAD rates increased slightly for men and decreased for women. In all the countries, the NAD rates were higher than the AD rates, and the rates were higher for men than for women. In the year 2011, the respective male and female mortality rates (per 1,000 people) because of non-avoidable causes were as follows: Argentina (4.8 and 3.9), Chile (3.7 and 2.4), Colombia (3.2 and 1.9) and Mexico (4.1 and 2.7). For AD, the respective figures were as follows (for men and women): Argentina (1.5 and 1.2), Chile (1.4 and 1.2), Colombia (1.5 and 1.4) and Mexico (1.7 and 1.6). In the period analyzed, the NAD rate for Colombian men decreased by 25.9%, whereas it increased by 4.3% in Mexico. The most marked reduction for AD was observed in Chile (26.1%), whereas it was shown to increase by 3% in Mexican men. Meanwhile, the NAD rates in Colombian and Chilean women decreased by slightly more than 10%, whereas in Argentine and Mexican women, these rates decreased by less than 2%. For AD, women in Argentina, Chile, Colombia and Mexico experienced a rate reduction of 18, 25, 20.8 and 6.6%, respectively.
Results
Mortality rates
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Contribution of causes of death to the change in life expectancy
Between 2000 and 2011, the countries studied experienced gains in life expectancy, particularly men in Colombia. However, in 2011, Colombia had the lowest life expectancy and Chile had the highest. The largest contributions to life expectancy were explained by NAD for men in all countries and for women in Argentina; in contrast, in Chile, Colombia and Mexico, the gains in years of life expectancy for women were mainly a result of avoidable causes (Table 2 ). An analysis of the 10 major causes of AD revealed important variations in changes in life expectancy between countries and by gender (Figure 2) . First, Mexican men did not lose life years from any of the avoidable diseases, whereas women in Argentina showed increased deaths from causes that contribute negatively to life expectancy: diabetes, respiratory diseases, incidents during medical and surgical care and other conditions (with a decrease of 0.15 years for these 4 causes). The remaining death causes contributed only minimally to the loss of life years. The cause underlying the largest gain in years of life expectancy between 0 and 74 years of age corresponded to maternal, congenital and perinatal conditions for men in Argentina (0.19), Chile (0.09), Colombia (0.37) and Mexico (0.20), as well as for women in Argentina (0.18) and Colombia (0.31). For men in Argentina, reduction in respiratory diseases was the main contribution to increases in life expectancy (0.19), whereas the main gains in life expectancy for women were decreases in deaths from diseases of the circulatory system (0.30) and tumors (0.26); for Chilean women, tumors (0.16) and other diseases of the circulatory system (0.14). In Colombia, another positive contribution to life expectancy for women was the treatment of other diseases of the circulatory system (0.18), and in Mexican women, infectious diseases (0.22) and respiratory diseases (0.16).
Contribution to the change in life expectancy by age groups
The decomposition of life expectancy by age and sex groups is presented in Figure 3 . In general, regarding NAD, the group composed of men between 50 and 74 years of age contributed the most years of life in Argentina (0. and the age groups 5-14 and 15-29 years (0.35 and 0.24, respectively) in Mexico played a similar role. Concerning AD, the male age groups that added more years to life expectancy were as follows: younger than 1 year of age in Argentina (0.26), Colombia (0.39), Chile (0.08) and Mexico (0.19), and adults aging between 50 and 74 years old in Colombia (0.10). Regarding women, the most significant increases in life expectancy because of NAD reduction were as follows: the age groups 30-49 years (0.22) and 50-74 years (0.33) in Argentina; the age groups 15-29 years (0.11 and 0.15, respectively) and 50-74 years (0.13 and 0.23, respectively) in Chile and Colombia, and the group of 1-4 years (0.33) in Mexico. The gains in temporary female life expectancy for reduction of AD in Argentina and Colombia were concentrated in children younger than 1 year of age (0.21 and 0.36, respectively) and in the age group of 50-74 years (0.28 and 0.24, respectively); in Chile, this gain was represented by women over 30 years of age and in the age group of 50-74 years (0.13 and 0.25, respectively); in Mexico, girls between 0 and 5 years of age had the highest contribution, both for NAD (0.41) and AD (0.36).
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Discussion
The objective of this study was to measure the contribution of AD and NAD reductions to the change in life expectancy in Argentina, Chile, Colombia and Mexico during the first decade of the 21st century. In general, the results suggest that reductions in mortality from these causes have resulted in gains in years of life expectancy in the region. Despite these achievements, differences between countries, gender and age groups are still present 2, 23, 24, 25, 26 .
The evidence is consistent with the declining trend in AD, both in low-income countries and in developed countries 17, 27, 28, 29 . For example, between 1999 and 2006/2007, the standardized mortality rate dropped in the United States, the United Kingdom, Germany and France. The reductions in Cad. Saúde Pública 2018; 34(6):e00093417 mortality rate from these causes were 18.5% for men and 17.5% for women in the United States and 36.9% for men and 31.9% for women in the United Kingdom 18 . Another study showed AD mortality rates experienced a downward trend in the United States and Canada between 1980 and 2006, particularly from tuberculosis, cerebrovascular disease, cervical cancer and peptic ulcers 27 . In Mexico, the adjusted rates of AD showed a decrease between the periods 1990-1994 and 1995-1999, although this decline was more pronounced between this last quinquennium and the period 2000-2004 28 . In the border states of the United States and Mexico, the adjusted rate of AD per 100,000 people decreased by 19% and 9.1%, respectively, between the periods 1999-2001 and 2009-2011 29 .
Several authors note that the health of the population in Latin America is due to a complex interplay of individual and contextual factors that have a particular impact on the life condition of individuals 1, 2, 4, 25, 30, 31 . Changes in demographic and epidemiological profiles have occurred in parallel with increased urbanization, increased literacy rates and incorporation of women into the paid labor market, thus influencing health risk behaviors such as malnutrition (overweight, obesity or undernutrition), alcoholism, smoking and physical inactivity, among others 4, 7, 32, 33, 34, 35 , all within a context of profound political, health, economic and social transformations that are still underway 1,2,6,31 . These processes have exacerbated the gaps in health, with a clear epidemiological polarization between places where CD and NCD coexist 4, 23 .
The findings support the concept that in recent years there has been an increase in life expectancy for children younger than 1 year, although infant mortality rates (per 1,000 live births) are still relatively high: Colombia (17.8), Mexico (13.3), Argentina (11.1) and Chile (7.4) 5 , as also shown in other contexts 36 . The persistently high infant mortality in the region is attributed, among other factors, to low income, high prevalence of teenage pregnancies and lack of access to basic health care services of an appropriate quality delivered in an opportune manner 37 .
However, the previously observed effect of NAD on the life expectancy of the Latin America and the Caribbean population was corroborated. A recent study found that between 2000 and 2011, the mortality rate from violence in Colombia decreased by 50%, whereas it increased by 191.2% between 2007 and 2011 in Mexico. In 2011, the mortality rate from homicides was 23.2 and 36.1 (per 100,000 people) in Mexico and Colombia, respectively 9 . The excess mortality from homicides is an increasingly important phenomenon in Mexico that has been identified as the triggering cause of the stagnation in life expectancy in that country 10, 38, 39, 40 . In Colombia, although the mortality rate from violence remains high, a gain of 1.13 years was recorded between 2000 and 2011 for men between 15 and 49 years of age 9 . Likewise, road accidents are another cause of NAD with a large effect on the life expectancy of the countries studied 11 : 0.86 in Mexico, 0.72 in Colombia, 0.66 in Argentina and 0.62 in Chile for the 2009-2011 triennium. The most affected population is men belonging to the age group 15-44 years 41 .
Even though external causes of death (such as homicides, suicides and traffic accidents) have an ample presence in the epidemiological profile of Latin America and the Caribbean 9,10,11,37,38,39,40,41,42 , they were not included in the avoidable causes of death classification. Given their complexity, they should be analyzed independently, considering that its approach should not only be restricted to the field of public health, but it also depends on wider public policies: social, economic, cultural, among others 42, 43 .
Although diabetes mellitus is a widespread public health problem in Latin America 10 , according to 2011 estimates, approximately 80% of years of potential life lost from diabetes in the countries studied (Argentina, Chile, Colombia and Mexico) occurred between 50 and 74 years of age 8 , and this figure is expected to increase because of the rapid population aging 1 . Mexicans alone lost 1.13 years of life expectancy between 2000 and 2011 due to this condition, a figure that is higher than in Colombia (0.24), Argentina (0.21) and Chile (0.18) 8 . The obesity prevalence in adults 20 years of age and older is 33% in Mexico, 29% in Chile and Argentina, and 18% in Colombia, whereas the percentage worldwide is 23% 44 .
Given the relevance of the issue of AD and NAD in Latin America and the Caribbean, planning and developing a common agenda in which the exchange of experiences, resources and efforts 2 is encouraged to effectively confront the mortality gaps observed in the different social groups is essential. Moreover, each country must consider specific approaches, according to its particularities and the effect of these deaths on its life expectancy. First, identifying the current epidemiological profile
Cad. Saúde Pública 2018; 34(6):e00093417 and the level of health care required is fundamental, as well as focusing efforts on preventive actions that reduce or mitigate the effect of certain diseases on the health and well-being of individuals. Second, widespread coverage and equitable access to health care must be provided with efficiency to ensure that the most vulnerable populations (such as children, women, indigenous communities and persons of African descent, among others) will have their basic needs covered. These tasks must be aimed at eliminating inequalities mediated by variables such as gender, age, social status, ethnicity, education level and geographic area of residence, which have a differential and unjust effect on the health status of communities 24, 25, 30, 31, 32 .
The AD and NAD criteria employed in this study, together with the estimate of the life expectancy change, are useful for analyzing the evolution of mortality in Latin America from a different point of view and for highlighting those conditions that require action in the immediate future. However, the AD indicator by itself is not enough to monitor the health status of a population 44 ; thus, moving forward with the revision of concepts 28 and causes of death that comprehensively reflect the reality of Latin America and the Caribbean, improving the quality of the data on mortality 28 and adopting an approach that takes into account the contextual framework and social determinants that affect health conditions are essential measures 45 . A key issue to understand how the health of individuals in Latin America and the Caribbean has evolved is the organization of its health systems, characterized by fragmentation of services and financial segmentation and a poorly regulated private sector, which has resulted in overspending by patients and their families 31 .
Mortality is no longer a phenomenon that concerns the health sector exclusively because it covers a wider spectrum of life dimensions of AD with other economic sectors (both public and private, social and educational). This requires addressing the issue from an intersectoral point of view and with a multidisciplinary vision, in which the participation of individuals, families, governments as well as of the community in general is essential. In addition, an improved understanding of the health-disease processes must be complemented by monitoring for nonfatal effects of diseases and injuries through indicators such as disability-adjusted life years and healthy life-years lost, among others 26, 35, 46, 47 .
Although the contributions of this research are relevant, some underlying limitations must be considered based on the results obtained. First, errors associated with the quality and coverage of mortality vital statistics have been reported, such as completeness of death registration and of census enumeration, and age misreporting 48 . Despite this, recent studies show mortality registries in the selected countries have improved 49 , which allows reliable information to be available for the type of analysis made in this article. Second, there is no a unified avoidable death classification, which makes comparisons to be difficult among different countries; therefore, a unified list for the region that responds to its epidemiological and contextual reality would be convenient 28 .
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